Verastem (VSTM) Change in Cash (2011 - 2026)
Verastem (VSTM) recorded quarterly Change in Cash of -$39.4 million in Q1 2026, down 158.62% quarter-over-quarter from $67.3 million in Q4 2025, and down 237.17% on a YoY basis from $28.8 million in Q1 2025.
Verastem (VSTM) Change in Cash (2011 - 2026) Analysis & Trends
Verastem's Change in Cash history runs 16 years deep, the most recent figure standing at -$39.4 million for Q1 2026.
- In Q1 2026, Change in Cash fell 237.17% year-over-year to -$39.4 million; the TTM figure through Mar 2026 stood at $48.0 million (up 36.25% YoY), while the FY2025 annual figure was $116.2 million, up 1063.7% from the prior year.
- Change in Cash was -$39.4 million for Q1 2026 at Verastem, down from $67.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $85.6 million in Q2 2023 to a low of -$87.6 million in Q3 2023.
- Historically, Change in Cash has averaged $8.5 million across 5 years, with a median of $15.2 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Cash tumbled 676.46% in 2023, then surged 4492.63% in 2025.
- A 5-year view of Change in Cash shows it stood at -$3.6 million in 2022, then sank by 392.65% to -$17.7 million in 2023, then sank by 37.68% to -$24.4 million in 2024, then surged by 376.24% to $67.3 million in 2025, then sank by 158.62% to -$39.4 million in 2026.
- The last three Change in Cash figures came in at -$39.4 million (Q1 2026), $67.3 million (Q4 2025), and -$26.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -39.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.44 Mn |
| Dec 31, 2025 | 67.28 Mn |
| Sep 30, 2025 | -26.62 Mn |
| Jun 30, 2025 | 46.75 Mn |
| Mar 31, 2025 | 28.75 Mn |
| Dec 31, 2024 | -24.36 Mn |
| Sep 30, 2024 | 29.80 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 3.52 Mn |
| Dec 31, 2023 | -17.69 Mn |
| Sep 30, 2023 | -87.56 Mn |
| Jun 30, 2023 | 85.58 Mn |
| Mar 31, 2023 | 22.96 Mn |
| Dec 31, 2022 | -3.59 Mn |
| Sep 30, 2022 | 15.19 Mn |
| Jun 30, 2022 | 17.26 Mn |
| Mar 31, 2022 | 25.44 Mn |
| Dec 31, 2021 | -3.06 Mn |
| Sep 30, 2021 | -658,000.00 |
| Jun 30, 2021 | -10.54 Mn |